A Case of Sunitinib-Induced Destructive Thyroiditis.
- Author:
Bu Kyung KIM
1
;
Young Sik CHOI
;
Yo Han PARK
Author Information
- Publication Type:Case Report
- Keywords: Destructive thyroiditis; Sunitinib
- MeSH: Carcinoma, Renal Cell; Gastrointestinal Stromal Tumors; Humans; Hypothyroidism; Indoles; Pyrroles; Thyroid Gland; Thyroiditis
- From:Endocrinology and Metabolism 2012;27(1):68-71
- CountryRepublic of Korea
- Language:Korean
- Abstract: Sunitinib is a multi-targeted tyrosine-kinase inhibitor used for gastrointestinal stromal tumors and renal cell carcinoma (RCC). Several recent studies have reported sunitinib-induced hypothyroidism and thyroid dysfunction; however, the underlying mechanisms are not clear. Here, we report a patient with metastatic RCC, who developed destructive thyroidtis due to sunitinib treatment. The course followed in this case may be useful in understanding the clinical course of sunitinib-induced thyroiditis.
